Erlotinib Recruiting Phase 2 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02714530Thoracal Radiotherapy and Tarceva